AVITA Medical Inc. (RCEL): Kapitalisasi marang pendapatan

Simbol lan logo merek AVITA Medical Inc. (RCEL)

AVITA Medical, Inc. (RCEL) aims to secure a dominant position in the US hospital sector by scaling its regenerative technologies. The P/S time series illustrates the progress of this trajectory, with the latest mark standing at 5.90. However, expansion into aesthetic surgery and the struggle for B2B client loyalty in burn centers remain significant challenges for the business's capitalization.

RCEL Multiplikator P/S AVITA Medical Inc. (04.07.2022 - 13.11.2026)

Rincian analitis perusahaan AVITA Medical, Inc (RCEL)

- rega saham lan konsensus proyeksi valuasi:
Analisis umum perusahaan:RCEL avitamedical.com
Barang utama AVITA Medical, Inc.

To minimize the risk of overpaying for the asset, investors should compare the market capitalization of AVITA Medical, Inc. (RCEL) with annual sales volume, utilizing revenue multiple dynamics to identify overbought zones. The high operational efficiency of RECELL systems in regenerative medicine makes this metric a key measure of business value, where deviations from historical averages signal a potential correction should the expansion of innovative technologies slow down.

Pesaing AVITA Medical, Inc.

DXCM (dexcom.com) - Rasio kapitalisasi pasar marang pendapatan|Rasio rega marang pendapatan Penumbra PEN|NOVT - Kapitalisasi marang pendapatan|Haemonetics Corp. - Multiplikator P/S|Rega marang dodolan Inspire Medical Systems Inc|PRCT: Multiplikator P/S|Rasio kapitalisasi marang pendapatan CNMD|PLSE (Pulse Biosciences) - Multiplikator P/S|InMode Ltd (INMD) - Koefisien rega marang pendapatan|Multiplikator P/S PMI|Kapitalisasi marang pendapatan Surmodics Inc. SRDX|Multiplikator P/S SENS (Senseonics Holdings)|Multiplikator P/S neuropace.com NPCE|TCMD - Rasio rega marang pendapatan|SNWV: Rasio rega marang pendapatan|OM (Outset) - Kapitalisasi marang pendapatan|Electromed - Rasio kapitalisasi pasar marang pendapatan|LNSR (LENSAR, Inc.) - Multiplikator P/S|Rega marang dodolan Profound Medical Corporation PROF|Rasio rega marang pendapatan Baird Medical Investment (BDMD)|edap-tms.com (EDAP) - Multiplikator rega marang pendapatan|Apyx Medical Corporation - Kapitalisasi marang pendapatan|Multiplikator P/S IceCure Medical Ltd. ICCM|Pulmonx Corp. - Multiplikator P/S|Koefisien rega marang pendapatan TELA Bio, Inc. TELA|cytosorbents.com (CTSO) - Rasio rega marang pendapatan|Rasio rega marang dodolan SRTS (Sensus Healthcare Inc)|Rasio rega marang pendapatan Zynex Inc|Kapitalisasi marang pendapatan electroCore Medical (ECOR)|Multiplikator P/S RBOT|IINN - Rega marang dodolan|Rasio rega marang pendapatan SeaStar Medical ICU|IRIX: Rasio kapitalisasi marang pendapatan|INBS: Kapitalisasi marang pendapatan|Beyond Air, Inc. - Kapitalisasi marang volume dodolan|PFSA: Multiplikator P/S|STRATA Skin Sciences, Inc. (SSKN) - Multiplikator P/S|Kapitalisasi marang pendapatan GCTK|Rasio rega marang pendapatan NAOV|Multiplikator P/S VERO|Koefisien rega marang pendapatan Nuwellis Corp|Aethlon Medical - Kapitalisasi marang pendapatan|Kapitalisasi marang volume dodolan ASXC (Asensus Surgical Inc)|Avinger - Multiplikator P/S|BSGM - Multiplikator P/S|CUTR (Cutera, Inc) - Kapitalisasi marang pendapatan|Know Labs Corporation - Rasio kapitalisasi pasar marang pendapatan|Rasio rega marang pendapatan Inari Medical, Inc.|Kapitalisasi marang pendapatan nevro.com (NVRO)|Multiplikator P/S RSLS|SILK - Rega marang dodolan